Results 161 to 170 of about 233,546 (312)
Learning cultures in online education
Nataly Tcherepashenets
doaj +1 more source
Hospitalisations and idiopathic pulmonary fibrosis: lessons from two continents. [PDF]
Okereke J, Hart SP, Dempsey TM.
europepmc +1 more source
What can objects reveal about the motivations behind and impact of Britain’s conquest and colonisation of a quarter of the world’s peoples – or that of similar acts by other European states?
Martin, Emma, Heath, Deana
core
Invasive freshwater bivalves harm native species, ecosystems and biodiversity, and incur economic costs. The enemy release hypothesis posits that invasive species are released from enemies during the invasion process, giving them a competitive advantage in the new environment.
Binglin Deng +8 more
wiley +1 more source
Nataly Tcherepashenets
doaj +1 more source
Assessing production of 38K suitable for PET imaging via 38Ar(p, n)38K, 38Ar(d,2n)38K, and 36Ar(t, n)38K reactions using GEANT4, EMPIRE, and TALYS codes. [PDF]
Isazadeh F, Saray AA.
europepmc +1 more source
A parallel of ruins and landscapes
A parallel of ruins and landscapes pairs two extensive fieldworks that unfolded in the past fifty years in the American West: the first by Reyner Banham, and the second by Ludovico Centis.
Centis, Ludovico, The Empire
core
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source
Effects of empagliflozin on right ventricular free-wall strain in patients with heart failure and reduced ejection fraction: results from the Empire HF Trial. [PDF]
Omar M +13 more
europepmc +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source

